Literature DB >> 15367633

Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.

Pey-Jium Chang1, George Miller.   

Abstract

A transcriptional activator encoded in open reading frame 50 (ORF50) of Kaposi's sarcoma-associated herpesvirus (KSHV) initiates the viral lytic cycle. ORF50 protein activates downstream KSHV target genes by at least two mechanisms: direct recognition of response elements in promoter DNA and interaction with cellular proteins bound to promoter DNA. We have identified a multifunctional regulatory region, present in amino acids (aa) 520 to 535 of ORF50 protein, that controls DNA binding and protein stability. Deletion of aa 521 to 534 or mutation of a basic motif (KKRK) in this regulatory region dramatically enhances DNA binding by ORF50 protein, as shown by electrophoretic mobility shift, DNA affinity chromatography, and chromatin immunoprecipitation assays. Deletion of the regulatory region and mutations in the KKRK motif also lead to abundant expression of an electrophoretic mobility variant, ORF50B, which appears to be a form of ORF50 protein that is decreased in posttranslational modification. Enhanced DNA binding and enhanced expression of ORF50B are independent phenomena. The regulatory region likely inhibits DNA binding through interactions with the DNA binding domain in aa 1 to 390 and destabilizes ORF50B through interactions with a domain located in aa 590 to 650. Mutants in the KKRK motif that are enhanced in DNA binding are nonetheless impaired in activating direct targets, such as polyadenylated nuclear RNA, and indirect targets, such as ORF50 itself. The identification of an autoregulatory region emphasizes that the many functions of ORF50 protein must be subject to exquisite control to achieve optimal KSHV lytic-cycle gene expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367633      PMCID: PMC516418          DOI: 10.1128/JVI.78.19.10657-10673.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Haque; J Chen; K Ueda; Y Mori; K Nakano; Y Hirata; S Kanamori; Y Uchiyama; R Inagi; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.

Authors:  J Chen; K Ueda; S Sakakibara; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

Authors:  M J Song; H J Brown; T T Wu; R Sun
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

Authors:  J Jeong; J Papin; D Dittmer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50.

Authors:  Y Gwack; H Byun; S Hwang; C Lim; J Choe
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase.

Authors:  L Burýsek; P M Pitha
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.

Authors:  J Goudsmit; N Renwick; N H Dukers; R A Coutinho; S Heisterkamp; M Bakker; T F Schulz; M Cornelissen; G J Weverling
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

8.  Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.

Authors:  L Gradoville; J Gerlach; E Grogan; D Shedd; S Nikiforow; C Metroka; G Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus.

Authors:  Hongyu Deng; Arthur Young; Ren Sun
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

10.  Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.

Authors:  D M Lukac; J R Kirshner; D Ganem
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

View more
  28 in total

1.  Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA.

Authors:  Pey-Jium Chang; Duane Shedd; George Miller
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus.

Authors:  Lee-Wen Chen; Pey-Jium Chang; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Transcriptional repression of K-Rta by Kaposi's sarcoma-associated herpesvirus K-bZIP is not required for oriLyt-dependent DNA replication.

Authors:  Cyprian Rossetto; Yang Gao; Irena Yamboliev; Iva Papousková; Gregory Pari
Journal:  Virology       Date:  2007-09-21       Impact factor: 3.616

4.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer.

Authors:  Wei Bu; Kyla Driscoll Carroll; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

5.  Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein.

Authors:  Pey-Jium Chang; Joseph Boonsiri; Shih-Shan Wang; Li-Yu Chen; George Miller
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

6.  Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL.

Authors:  Diana Palmeri; Kyla Driscoll Carroll; Olga Gonzalez-Lopez; David M Lukac
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  Role of Litopenaeus vannamei Yin Yang 1 in the Regulation of the White Spot Syndrome Virus Immediate Early Gene ie1.

Authors:  Ping-Han Huang; Ting-Yi Huang; Pei-Si Cai; Li-Kwan Chang
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

8.  Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.

Authors:  Jiguo Chen; Fengchun Ye; Jianping Xie; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

9.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

10.  Phosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt.

Authors:  Maria E McDowell; Pravinkumar Purushothaman; Cyprian C Rossetto; Gregory S Pari; Subhash C Verma
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.